YBL-011

YBL-011

YBL-011

> R&D > Pipeline > YBL-011

• Synergistic effect when combined with anti-PD-1 and anti-PD-L1

• 3 times higher T cell activation compared to competitors

• Synergistic effect when combined with anti-PD-1 and anti-PD-L1

• 3 times higher T cell activation compared to competitors